Canada Varicose Vein Treatment Devices Market Forecast To Grow USD 77 Million By 2028

Comments · 504 Views

The Canada varicose vein treatment devices market size was valued at USD 48.0 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% over the forecast period.

Canada Varicose Vein Treatment Devices Industry Overview

The Canada varicose vein treatment devices market size was valued at USD 48.0 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% over the forecast period.

The rising cases of varicose veins and increasing adoption of endovenous ablation are key factors driving the growth of the market. According to a study published in National Center for Biotechnology Information (NCBI), nearly 3.7 million people have varicose veins in Canada. Furthermore, rising awareness among patients regarding venous diseases is anticipated to favor market growth. The rising demand for minimally invasive treatment options, approval from Health Canada for various ablation devices sclerotherapies, and positive recommendations from associations, such as Ontario Health Technology Advisory Committee (OHTAC) for Endovenous Laser Ablation (EVLA) Radiofrequency Ablation (RFA), is anticipated to drive the market.

Gather more insights about the market drivers, restrains and growth of the Canada Varicose Vein Treatment Devices Market

The non-invasive techniques for treating varicose veins have been found to have similar effectiveness as invasive surgeries as per the latest studies, resulting in more preference for minimally invasive procedures. These minimally invasive procedures have a lot of other merits over invasive surgeries. In recent times, technological advancements have resulted in the emergence of minimally invasive surgeries. Endovenous ablation sclerotherapy are noninvasive surgeries for treating varicose veins. Endovenous ablation consists of radiofrequency and laser procedures. The radiofrequency procedure is used more where the vein is thermally heated at a temperature of 60 °C to 100 °C. Sclerotherapy involves injecting a salt solution into the vein irritating the blood vessel lining, collapsing sticking together making a blood clot. These minimally invasive techniques are being preferred more in recent years over invasive surgeries.

In Canada, reimbursement and health insurance coverage for varicose veins depends on the type of treatment. Public healthcare in Canada provides coverage for conventional vein stripping and ligation surgery sclerotherapy. The Ontario Health Insurance Plan (OHIP) emphasizes conservative management of varicose veins before more invasive procedures. In 2019, the Ontario Health Technology Advisory Committee (OHTAC) recommended coverage for compression therapy for patients; however, medical-grade compression stockings are not publicly funded for most patients.

Browse through Grand View Research's Medical Devices Industry Research Reports

  • Ocular Adhesives And Sealants Market: The global ocular adhesives and sealants market size was valued at USD 136.7 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.28% from 2022 to 2030.
  • Dental Imaging Market: The dental imaging market is thriving owing to the increasing demand for cosmetic dentistry and technological advancements for early detection. The increasing prevalence of dental diseases and the aging population has resulted in higher utilization of dental services.

Canada Varicose Vein Treatment Devices Market Segmentation

Grand View Research has segmented the Canada varicose vein treatment devices market on the basis of type and end use:

Canada Varicose Vein Treatment Devices Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Endovenous Ablation
  • Sclerotherapy
  • Surgical Ligation Stripping

Canada Varicose Vein Treatment Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Ambulatory Care Unit
  • Vein Clinics
  • Hospitals 

Market Share Insights

  • February 2020: biolitec AG announced the launch of ELVeS Radial 2ring Pro, an advanced laser fiber for endovenous laser treatment of severely tortuous varicose veins.
  • August 2019: Boston Scientific Corp. acquired BTG, which resulted in the inclusion of Varithena and the expansion of its portfolio in minimally invasive surgical devices. 

Key Companies profiled:

Some of the prominent players in the Canada varicose vein treatment devices market include:

  • Angiodynamics
  • Medtronic
  • Teleflex Incorporated
  • Sciton, Inc.
  • Biolitec AG
  • Dornier Medtech
  • Merit Medical Systems
  • Alma Lasers
  • Boston Scientific Corp. 

Order a free sample PDF of the Canada Varicose Vein Treatment Devices Market Intelligence Study, published by Grand View Research. 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments